Trial Profile
A Pilot study of IRX-2 in patients with early stage cervical cancer
Status:
Completed
Phase of Trial:
Clinical Phase Unknown
Latest Information Update: 16 Feb 2018
Price :
$35
*
At a glance
- Drugs IRX 2 (Primary)
- Indications Cervical cancer
- Focus Adverse reactions; Therapeutic Use
- 16 Feb 2018 New trial record